Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann T Mithoefer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Psychoactive Drugs|March 21, 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case ExampleAnne C Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Frontiers in Psychiatry|July 15, 2021
Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSDAnne C Wagner, Rachel E Liebman, Ann T Mithoefer, et al.
European Journal of Psychotraumatology|January 4, 2024
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorderRichard J Zeifman, Hannes Kettner, Stephen Ross, et al.
Journal of Psychopharmacology (Oxford, England)|June 22, 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapyMark T Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Psychoactive Drugs|March 21, 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case ExampleAnne C Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Frontiers in Psychiatry|July 15, 2021
Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSDAnne C Wagner, Rachel E Liebman, Ann T Mithoefer, et al.
European Journal of Psychotraumatology|January 4, 2024
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorderRichard J Zeifman, Hannes Kettner, Stephen Ross, et al.
Journal of Psychopharmacology (Oxford, England)|June 22, 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapyMark T Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Pageof 1